1. Home
  2. CRGX vs FPI Comparison

CRGX vs FPI Comparison

Compare CRGX & FPI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CRGX
  • FPI
  • Stock Information
  • Founded
  • CRGX 2021
  • FPI 2013
  • Country
  • CRGX United States
  • FPI United States
  • Employees
  • CRGX N/A
  • FPI N/A
  • Industry
  • CRGX
  • FPI Real Estate Investment Trusts
  • Sector
  • CRGX
  • FPI Real Estate
  • Exchange
  • CRGX Nasdaq
  • FPI Nasdaq
  • Market Cap
  • CRGX 621.4M
  • FPI 607.9M
  • IPO Year
  • CRGX 2023
  • FPI 2014
  • Fundamental
  • Price
  • CRGX $13.46
  • FPI $11.51
  • Analyst Decision
  • CRGX Strong Buy
  • FPI
  • Analyst Count
  • CRGX 6
  • FPI 0
  • Target Price
  • CRGX $31.80
  • FPI N/A
  • AVG Volume (30 Days)
  • CRGX 231.3K
  • FPI 283.9K
  • Earning Date
  • CRGX 03-20-2025
  • FPI 02-26-2025
  • Dividend Yield
  • CRGX N/A
  • FPI 2.08%
  • EPS Growth
  • CRGX N/A
  • FPI N/A
  • EPS
  • CRGX N/A
  • FPI 0.32
  • Revenue
  • CRGX N/A
  • FPI $58,465,000.00
  • Revenue This Year
  • CRGX N/A
  • FPI N/A
  • Revenue Next Year
  • CRGX N/A
  • FPI N/A
  • P/E Ratio
  • CRGX N/A
  • FPI $35.82
  • Revenue Growth
  • CRGX N/A
  • FPI 1.30
  • 52 Week Low
  • CRGX $10.91
  • FPI $9.70
  • 52 Week High
  • CRGX $33.92
  • FPI $12.85
  • Technical
  • Relative Strength Index (RSI)
  • CRGX 47.00
  • FPI 44.63
  • Support Level
  • CRGX $12.51
  • FPI $11.37
  • Resistance Level
  • CRGX $15.75
  • FPI $11.90
  • Average True Range (ATR)
  • CRGX 1.09
  • FPI 0.24
  • MACD
  • CRGX 0.17
  • FPI -0.00
  • Stochastic Oscillator
  • CRGX 52.74
  • FPI 37.25

About CRGX CARGO Therapeutics Inc.

Cargo Therapeutics Inc is a clinical-stage biotechnology company positioned to advance next generation, potentially curative cell therapies for cancer patients. It programs, platform technologies, and manufacturing plan are designed to directly address the key limitations of approved cell therapies, including limited durability of effect, suboptimal safety and unreliable supply. The company's program, CRG-022, is a novel CAR T-cell product candidate designed to address resistance mechanisms by targeting CD22, an alternate tumor antigen that is expressed in a vast majority of B-cell malignancies.

About FPI Farmland Partners Inc.

Farmland Partners Inc owns and seeks to acquire high-quality farmland throughout North America. The company is an internally managed real estate company which owns and contracts farmland and storage facilities located across the United States. Majority of the properties in its portfolio are used to grow primary crops, such as corn, soybeans, wheat, rice and cotton, and rest to produce specialty crops, such as almonds, citrus, blueberries, and vegetables. The company generates its revenues through the rent it receives from its tenants.

Share on Social Networks: